secwatch / observer
8-K filed September 20, 2023, 7:59 PM ET ticker KBH CIK 0000795266
earnings confidence high sentiment neutral materiality 0.70

KB Home Q3 EPS $1.80 beats guidance; net orders up 52% to 3,097

KB HOME

2023-Q3 EPS reported $5.18 revenue$4,736,641,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

KB HOME reported nine months ended August 31, 2023 results: revenue $4.74 billion, net income $439.9 million, EPS $5.18.

Period
nine months ended August 31, 2023
Revenue
$4.74 billion
Net income
$439.9 million
EPS
$5.18
Result
reported results
Exact text from the filing
31, 2023 (comparisons on a year-over-year basis) • Homes delivered of 9,829 were roughly the same. • Average selling price was $479,200, compared to $497,200. • Revenues totaled $4.74 billion, compared to $4.96 billion. • Net income was $439.9 million, compared to $600.3 million. • Diluted earnings per share were $5.18, compared to $6.63. Backlog and Net Orders
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

KB HOME reported three months ended August 31, 2023 results: revenue $1.59 billion, net income $149.9 million, EPS $1.80.

Period
three months ended August 31, 2023
Revenue
$1.59 billion
Net income
$149.9 million
EPS
$1.80
Result
reported results
Exact text from the filing
Relations Contact (310) 893-7456 or jpeters@kbhome.com Cara Kane, Media Contact (321) 299-6844 or ckane@kbhome.com KB HOME REPORTS 2023 THIRD QUARTER RESULTS Revenues of $1.59 Billion; Diluted Earnings Per Share of $1.80 Repurchased 1.5 Million Shares for $82.5 Million; Book Value Per Share Increased to $48.29 Net Orders Increased 52% to 3,097 LOS ANGELES
View on SEC.gov

Browse all earnings releases →

KB HOME filing history →

Source: SEC EDGAR
accession 0000795266-23-000095
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.